Taro Pharmaceuticals U.S.A., Inc., its affiliates and
business units (collectively, "Taro") invites residents of the United States to
access and use this internet site subject to the following terms and conditions
and all applicable laws. This site and all information contained herein are
intended for access and use by U.S. residents only. If you do not agree with
these terms of use, please do not use this site. The terms of use may be
revised by Taro from time to time and you should therefore review them on your
next visit to this site.
THIS SITE AND THE INFORMATION CONTAINED OR REFERENCED HEREIN IS PROVIDED "AS
IS". TARO MAKES NO REPRESENTATION OR WARRANTY OF ANY KIND (INCLUDING
REPRESENTATIONS OR WARRANTIES AS TO THE ACCURACY OR COMPLETENESS OF ANY
INFORMATION CONTAINED OR REFERENCED ON THIS SITE), EITHER EXPRESS OR IMPLIED,
INCLUDING, BUT NOT LIMITED TO, THE IMPLIED WARRANTIES OF MERCHANTABILITY,
FITNESS FOR A PARTICULAR PURPOSE, OR NON-INFRINGEMENT. TARO EXPRESSLY DISCLAIMS
ANY OBLIGATION TO UPDATE SAID INFORMATION. TARO FURTHER ASSUMES NO LIABILITY OR
RESPONSIBILITY FOR ANY ERRORS OR OMISSIONS IN THE CONTENT OF THIS SITE.
Information available on this site is not provided with the intention of
offering medical advice for the use or application of Taro's products. Users of
Taro's products are advised to carefully read the patient information and
instructions for use which accompany all products and to consult their treating
physician with all questions as to the administration of such products.
Any communication from you to Taro via this site shall be deemed to be
non-confidential and non-proprietary. Taro shall be free to use any ideas,
concepts, know-how or techniques contained in such communication for any
purpose and to reproduce and disclose the information to third parties without
limitation.
Personal data available to Taro through your browsing and other usage of this
site is processed only in accordance with the guidelines established in the
Privacy Statement (see below).
This site may contain links to non-Taro websites and third-party information.
Please note that the contents of such websites and such third-party information
cannot be controlled or influenced by Taro. Any such links or information are
provided merely as a convenience, and Taro shall not be liable for any use
thereof by visitors to this site. In addition, a link to a non-Taro website
does not mean that Taro endorses or accepts any responsibility for the content
of such website, or the consequences of your use thereof.
ALL USERS OF THIS SITE AGREE THAT ACCESS TO AND USE OF THIS SITE AND THE
CONTENTS THEREOF ARE AT THEIR OWN RISK. IN NO EVENT WILL TARO BE LIABLE TO ANY
PARTY FOR ANY DIRECT, INDIRECT, INCIDENTAL, SPECIAL, CONSEQUENTIAL OR PUNATIVE
DAMAGES RESULTING FROM ANY USE OF, ACCESS OF OR INABILITY TO USE THIS WEBSITE,
THE INFORMATION CONTAINED HEREIN, OR ANY OTHER HYPERLINKED OR REFERENCED
WEBSITE, INCLUDING, WITHOUT LIMITATION, ANY LOST PROFITS, BUSINESS
INTERRUPTION, LOSS OF PROGRAMS OR OTHER DATA ON YOUR INFORMATION HANDLING
SYSTEM OR OTHERWISE, EVEN IF WE ARE EXPRESSLY ADVISED OF THE POSSIBILITY OF
SUCH DAMAGES.
Please note that it is Taro's policy to enforce its intellectual property
rights to the fullest extent of the law, including seeking criminal sanctions.
The images and information contained in this website are, to the fullest extent
possible, copyrighted and otherwise proprietary. Unless otherwise specified,
the trademarks, logos and service marks (collectively the "Trademarks")
displayed on this site, whether or not appearing in different type or with the
trademark symbol, are registered and non-registered trademarks or service marks
owned or licensed by Taro, its affiliates, or related companies. Lotrisone® is
a trademark of the Schering Corporation, a wholly-owned subsidiary of
Schering-Plough Corporation. Nothing on this site should be construed as
granting, by implication or otherwise, any license or right in or to the
Trademarks without the express written permission of Taro or any such third
party. The use or misuse of these Trademarks or any other materials, except as
permitted herein, is expressly prohibited and may be in violation of copyright
law, trademark law, the law of slander and libel, the law of privacy and
publicity, and communications regulations and statutes. Taro hereby authorizes
you to copy documents or pages published by Taro on this web site for your
personal, noncommercial use only, provided any copy of these documents that you
make retains all copyright or other proprietary notices and any disclaimer
contained thereon. Any other reproduction, retransmission, modification or use
of this site's contents requires the prior written consent of Taro.
Taro reserves the right to alter the content of this website in any way, at any
time, for any reason, without prior notification, and will not be liable in any
way for possible consequences of such changes.
IMPORTANT SAFETY INFORMATION
U-Kera E is indicated for debridement and promotion of normal healing of hyperkeratotic surface lesions, particularly where healing is retarded by local infection, necrotic tissue, fibrinous or purulent debris or eschar.
Urea is useful for the treatment of hyperkeratotic conditions such as dry, rough skin, dermatitis, psoriasis, xerosis, ichthyosis, eczema, keratosis, keratoderma, corns and calluses, as well as damaged nails, ingrown nails and devitalized nails.
U-Kera E is contraindicated in patients with known hypersensitivity to any of the listed ingredients. Local adverse reactions that may occur and normally disappear on discontinuing use include transient stinging, burning, itching and irritation. If redness or irritation occurs, discontinue use. Contact with eyes, lips or mucous membranes should be avoided. See full Prescribing
Information.